![Peter J. Langecker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter J. Langecker
Plus aucun poste en cours
Profil
Peter J.
Langecker served as President, Chief Executive Officer & Director at Oncotelic Therapeutics, Inc. from 2009 to 2014.
Prior to that, he was a Director at Xcyte Therapies, Inc. from 1999 to 2006 and Vice President-Clinical Affairs at Sugen, Inc. from 1997 to 1999.
He also held positions as Director-Clinical Research at Schering-Plough Corp.
and Vice President-Clinical Research at Coulter Pharmaceuticals, Inc. Additionally, he served as Chief Medical Officer at DURECT Corp.
from 2006 to 2009 and Chief Medical Officer & VP-Clinical Affairs at Intarcia Therapeutics, Inc. from 1999 to 2006.
Dr. Langecker earned a doctorate degree from Ludwig-Maximilians-Universität München.
Anciens postes connus de Peter J. Langecker
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Directeur Général | 15/05/2014 |
| DURECT | Directeur Technique/Scientifique/R&D | 16/06/2009 |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Directeur Technique/Scientifique/R&D | 01/04/2006 |
Xcyte Therapies, Inc.
 Xcyte Therapies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Directeur/Membre du Conseil | 30/03/2006 |
Sugen, Inc.
 Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/01/1999 |
Formation de Peter J. Langecker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Health Technology |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
DURECT Corp.
 DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
Xcyte Therapies, Inc.
Xcyte Therapies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Health Technology |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Cyclacel Pharmaceuticals, Inc.
 Cyclacel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes mechanism-targeted drugs to treat human cancers | Health Technology |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
